External Advisory Committee
The External Advisory Committee (EAC) consists of 7 key opinion leaders who provide an unbiased opinion on study performance and outcome, including decision making regarding project status and termination if interim analysis demonstrates no benefit of the trial agent.
John C. Byrd, MD
Professor
Department of Internal Medicine & Division of Hematology
Comprehensive Cancer Center
Ohio State University
Will C. Eward, DVM, MD
Assistant Professor
Orthopedic Surgery
Duke Cancer Institute
Brant A. Inman, MD, MS
Associate Professor
Surgical Oncologist
Urologic Oncologist
Duke University
Steve J. Russell, MD, PhD
Consultant / Professor
Department of Molecular Medicine
Division of Hematology
Department of Internal Medicine
Mayo Clinic
George Demetri, MD
Professor/Director
Center for Sarcoma & Bone Oncology
Dana-Farber Cancer Institute
Executive Director, Clinical & Translational Research
Ludwig Institute for Cancer Research
Mario Sznol, MD
Professor
Co-Director, Cancer Immunology Program, Yale Cancer Center
Co-Director, Yale SPORE in Skin Cancer
Crystal Mackall, MD
Professor
Pediatrics & Internal Medicine
Stanford University School of Medicine